好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2018 Annual Meeting | C84 - Evidence Based Neurology Foresights for Busy Clinicians

Monday 04/23/18
03:30 PM - 05:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Andrei Ivashynka, MD, PhD
Practice, Policy, and Ethics
Participants should be able to become familiar with the quality assessment of the systematic review and meta-analysis findings in neurological practice; use the data of Systematic Review to answer the question what kind of Modifiable Risk Factors are significantly important for Multiple Sclerosis progression; practical application of Guidelines in routine clinical work; use the data of the Guideline to answer the question what kind of Risk Factors are significantly important for Sudden Unexpected Death.
2.00 CME credits
Medical Knowledge, Practice-based Learning and Improvement
Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist
Didactic, Audience Participation
Event Timeline
03:30 PM - 04:10 PM Speaker Quality Assessment of Systematic Reviews and Meta-Analyses in Examples
Gary S. Gronseth, MD, FAAN
04:10 PM - 04:40 PM Speaker Interpretation of the Results of Systematic Reviews and Meta-Analyses in Examples
Andrei Ivashynka, MD, PhD
04:40 PM - 05:20 PM Speaker Sudden Unexpected Death in Epilepsy Incidence Rates and Risk Factors: Guideline Development and Application Discussion
Cynthia L. Harden, MD
05:20 PM - 05:30 PM Q&A Questions and Answers
Faculty Disclosures
Andrei Ivashynka, MD, PhD Dr. Ivashynka has nothing to disclose.
Cynthia L. Harden, MD Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
Gary S. Gronseth, MD, FAAN Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain & Life. Dr. Gronseth has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as a Member/EBM consultant Guideline Development Subcommittee with AAN.